Cost-effectiveness of posaconazole <it>versus </it>fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

Cost-effectiveness of posaconazole <it>versus </it>fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

<p>Abstract</p> <p>Background</p> <p>We evaluated the cost-effectiveness of posaconazole compared with standard azole therapy (SAT; fluconazole or itraconazole) for the prevention of invasive fungal infections (IFI) and the reduction of overall mortality in high-risk ne...

Full description

Bibliographic Details
Main Authors: Grau Santiago, de la Cámara Rafael, Sabater Francisco J, Jarque Isidro, Carreras Enric, Casado Miguel A, Sanz Miguel A
Format: Article
Language:English
Published: BMC 2012-04-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/12/83

Internet

http://www.biomedcentral.com/1471-2334/12/83

Similar Items